Constellium Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Constellium de 37.8% y 6.3% por año respectivamente. Se prevé que el BPA crezca en un 37.2% al año. Se espera que la rentabilidad financiera sea de 25.1% en 3 años.
Información clave
37.8%
Tasa de crecimiento de los beneficios
37.4%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Metals and Mining | 17.6% |
Tasa de crecimiento de los ingresos | 6.3% |
Rentabilidad financiera futura | 25.1% |
Cobertura de analistas | Good |
Última actualización | 07 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
We Think That There Are More Issues For Constellium (NYSE:CSTM) Than Just Sluggish Earnings
May 01Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts
Apr 28Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate
Apr 16Is Constellium (NYSE:CSTM) Using Too Much Debt?
Mar 29Constellium (NYSE:CSTM) Is Doing The Right Things To Multiply Its Share Price
Mar 11Constellium: Solid Fundamentals And Attractive Valuation, Despite Macro Headwinds
Jan 29Constellium SE (NYSE:CSTM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jan 08Potential Upside For Constellium SE (NYSE:CSTM) Not Without Risk
Dec 18Constellium (NYSE:CSTM) Use Of Debt Could Be Considered Risky
Nov 23Constellium: Sensitivity To Exogenous Factors Capping Upside Potential, Rate Hold
Oct 26Are Investors Undervaluing Constellium SE (NYSE:CSTM) By 33%?
Sep 21Constellium: Strong Q2 2023 Results Support Long-Term Investment Thesis
Aug 03Here's Why Constellium (NYSE:CSTM) Is Weighed Down By Its Debt Load
Jul 27Constellium (NYSE:CSTM) Has No Shortage Of Debt
Apr 26Here's Why We Think Constellium (NYSE:CSTM) Is Well Worth Watching
Mar 13Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 23Constellium Q4 2022 Earnings Preview
Feb 21Constellium sells Ussel plant
Feb 03Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jan 09An Intrinsic Calculation For Constellium SE (NYSE:CSTM) Suggests It's 45% Undervalued
Nov 17Constellium Q3 2022 Earnings Preview
Oct 25Constellium supplying aluminium Auto Body Sheet solutions to car manufacturer
Sep 13Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?
Sep 06Constellium EPS of -€0.24, revenue of €2.28B beats by €240M
Jul 27Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jul 25Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?
May 31Constellium: A Discounted Play On Secular Aluminum Tailwinds
Apr 25Constellium SE's (NYSE:CSTM) Intrinsic Value Is Potentially 97% Above Its Share Price
Mar 21Constellium: An Overlooked Automotive Transformation Vehicle
Dec 30Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Dec 24Calculating The Fair Value Of Constellium SE (NYSE:CSTM)
Sep 10Constellium Is An Overlooked And Grossly Undervalued Opportunity
Aug 25Here's Why Constellium (NYSE:CSTM) Has A Meaningful Debt Burden
Jul 10Constellium rising as it's set to join Russell 3000 index
Jun 08Constellium (NYSE:CSTM) Is Posting Promising Earnings But The Good News Doesn’t Stop There
May 05Calculating The Intrinsic Value Of Constellium SE (NYSE:CSTM)
Apr 29Constellium Q1 2021 Earnings Preview
Apr 27Here's What Analysts Are Forecasting For Constellium SE (NYSE:CSTM) After Its Full-Year Results
Mar 01Did Business Growth Power Constellium's (NYSE:CSTM) Share Price Gain of 229%?
Feb 08CSTM, ARNC, VALE, FCX rated top industrial stocks at Deutsche Bank
Jan 13Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 8,342 | 339 | N/A | N/A | 1 |
12/31/2025 | 7,853 | 338 | 295 | 700 | 5 |
12/31/2024 | 7,317 | 253 | 141 | 568 | 6 |
3/31/2024 | 7,014 | 121 | 190 | 526 | N/A |
12/31/2023 | 7,239 | 125 | 169 | 506 | N/A |
9/30/2023 | 7,470 | 143 | 130 | 449 | N/A |
6/30/2023 | 7,772 | 209 | 126 | 449 | N/A |
3/31/2023 | 8,097 | 144 | 118 | 427 | N/A |
12/31/2022 | 8,120 | 301 | 178 | 451 | N/A |
9/30/2022 | 7,982 | 280 | 173 | 441 | N/A |
6/30/2022 | 7,547 | 247 | 136 | 378 | N/A |
3/31/2022 | 6,790 | 388 | 107 | 340 | N/A |
12/31/2021 | 6,152 | 257 | 125 | 357 | N/A |
9/30/2021 | 5,689 | 274 | 138 | 310 | N/A |
6/30/2021 | 5,274 | 196 | 174 | 330 | N/A |
3/31/2021 | 4,787 | 56 | 108 | 265 | N/A |
12/31/2020 | 4,883 | -21 | 152 | 334 | N/A |
9/30/2020 | 5,012 | -25 | 143 | 370 | N/A |
6/30/2020 | 5,301 | -44 | 98 | 339 | N/A |
3/31/2020 | 5,808 | 5 | 190 | 459 | N/A |
12/31/2019 | 5,907 | 59 | 176 | 447 | N/A |
9/30/2019 | 5,933 | -20 | 69 | 366 | N/A |
6/30/2019 | 5,900 | 196 | 22 | 332 | N/A |
3/31/2019 | 5,836 | 235 | -67 | 222 | N/A |
12/31/2018 | 5,686 | 188 | -211 | 66 | N/A |
9/30/2018 | 5,536 | 166 | -218 | 43 | N/A |
6/30/2018 | 5,387 | -29 | -180 | 73 | N/A |
3/31/2018 | 5,295 | -68 | -163 | 100 | N/A |
12/31/2017 | 5,237 | -31 | N/A | 160 | N/A |
9/30/2017 | 5,150 | 30 | N/A | 157 | N/A |
6/30/2017 | 5,070 | 24 | N/A | 121 | N/A |
3/31/2017 | 4,921 | 17 | N/A | 211 | N/A |
12/31/2016 | 4,743 | -4 | N/A | 88 | N/A |
9/30/2016 | 4,704 | -414 | N/A | 212 | N/A |
6/30/2016 | 4,764 | -474 | N/A | 252 | N/A |
3/31/2016 | 4,910 | -530 | N/A | 440 | N/A |
12/31/2015 | 5,153 | -554 | N/A | 368 | N/A |
9/30/2015 | 4,967 | -141 | N/A | 334 | N/A |
6/30/2015 | 4,635 | -85 | N/A | 330 | N/A |
3/31/2015 | 4,176 | -10 | N/A | 228 | N/A |
12/31/2014 | 3,666 | 51 | N/A | 173 | N/A |
9/30/2014 | 3,536 | 100 | N/A | 227 | N/A |
6/30/2014 | 3,471 | 130 | N/A | 231 | N/A |
3/31/2014 | 3,467 | 126 | N/A | 227 | N/A |
12/31/2013 | 3,495 | 94 | N/A | 184 | N/A |
9/30/2013 | 3,503 | 123 | N/A | 266 | N/A |
6/30/2013 | 3,526 | 131 | N/A | 279 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (37.8% al año) de CSTM es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (37.8% al año) de CSTM crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de CSTM crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (6.3% al año) de CSTM crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 6.3% al año) de CSTM crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CSTM sea alta dentro de 3 años (25.1%)